Articles

Ibrutinib for relapsed/refractory chronic lymphocytic leukemia: a UK and Ireland analysis of outcomes in 315 patients

Vol. 101 No. 12 (2016): December, 2016 https://doi.org/10.3324/haematol.2016.147900